Published in Obesity and Diabetes Week, August 7th, 2006
Study 1: The methylene-tetrahydrofolate reductase C677 T polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with type 2 diabetes.
According to a study from Belgium, "Individuals with type 2 diabetes are at increased risk of stroke. Plasma homocysteine (tHcy) is an independent risk factor for cardiovascular (CV) disease. The methylene-tetrahydrofolate reductase (MTHFR) gene polymorphism (thermolabile variant C677 T) is associated with CV risk, partly as a result of increased Hcy, especially in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.